The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: A multicenter, prospective, randomized controlled study
International Urology and Nephrology Jan 11, 2018
Fu N, et al. - In a study population comprising patients with coronary heart disease undergoing percutaneous coronary intervention (PCI), researchers investigated the preventive effect of probucol combined with hydration on contrast-induced nephropathy (CIN). A more effective decrease in the incidence of CIN was reported with probucol combined with hydration, relative to hydration alone, in this patient population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries